JOSEP MARIA RONCERO VIDAL

Haematology

Pomares AA, Merino LR, González S, Morata J, Tonda R, Arribas P, Revert J, Carrillo E, Grande C, Roncero JM, de Oteyza JP, Nicolás C, Gutierrez N, Abrisqueta P, Gutiérrez A, Ramírez-Páyer Á, Garcia-Sancho AM, González-Barca E, Montes-Moreno S

Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.

Plos One, 2025, 20 dx.doi.org/10.1371/journal.pone.0318689

Haematology

Witzig TE, Sokol L, Kim WS, de la Cruz F, Martin Garcia-Sancho AM, Advani RH, Roncero Vidal JM, De Oña R, Marin-Niebla A, Izquierdo AR, Terol MJ MD, Domingo-Domenech E, Saunders A, Bendris N, Mackey J, Leoni M, Foss FM

Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma.

Blood Advances, 2024, 8, 4581-4592 dx.doi.org/10.1182/bloodadvances.2024012806

Haematology

Oliveira AC, Roncero JM, Ferrá C, Do Nascimento J, Rodriguez-Luaces M, Encuentra M, Domingo-Domenech E, López P, Gallardo D, Ribera JM, Sarrá J, Sureda A, González-Barca E

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117, 388-397 dx.doi.org/10.1007/s12185-022-03488-5

Haematology , Descriptive epidemiology, genetics and cancer prevention

Villavicencio A, Solans M, Zacarías-Pons L, Vidal A, Puigdemont M, Roncero JM, Saez M, Marcos-Gragera R

Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 dx.doi.org/10.3390/ijerph18020701

Medical Imaging , Haematology

Negre Busó M, Balliu Collgrós E, Ferran Sureda N, Velasco Nuño M, Roncero Vidal JM, Rubió Rodríguez A

Follicular dendritic cell tumor in the context of a Castleman disease in a patient with Diffuse Large B Cell Lymphoma: Diagnosis and follow-up with 18 F-FDG PET/CT.

Revista Espanola De Medicina Nuclear E Imagen Molecular, 2021, 40, 322-324 dx.doi.org/10.1016/j.remnie.2020.08.003

Medical Imaging , Haematology

Negre Busó M, Balliu Collgrós E, Rubió Rodríguez A, Peláez Hernández I, Mestre Fusco A, Roncero Vidal JM

Utility of the 18 F-FDG PET/CT in the diagnosis of the neurolymphomatosis: A case report.

Revista Espanola De Medicina Nuclear E Imagen Molecular, 2021, 40, 328-331 dx.doi.org/10.1016/j.remnie.2020.09.017

Haematology , Descriptive epidemiology, genetics and cancer prevention

Villavicencio A, Solans M, Auñon-Sanz C, Roncero JM, Marcos-Gragera R

Population-based survival of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain

CANCER EPIDEMIOLOGY, 2020, 69, 101841-101841 dx.doi.org/10.1016/j.canep.2020.101841

Haematology

Busó, MN, Collgrós, EB, Rodríguez, AR, Hernandez, IP, Fusco, AM, Vidal, JMR

Utility of the 18F-FDG PET/CT in the diagnosis of the neurolymphomatosis: a case report

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 40, 328-331 dx.doi.org/10.1016/j.remn.2020.06.021

Haematology

O'Connor OA, Özcan M, Jacobsen ED, Roncero JM, Trotman J, Demeter J, Masszi T, Pereira J, Ramchandren R, Beaven A, Caballero D, Horwitz SM, Lennard A, Turgut M, Hamerschlak N, d'Amore FA, Foss F, Kim WS, Leonard JP, Zinzani PL, Chiattone CS, Hsi ED, Trümper L, Liu H, Sheldon-Waniga E, Ullmann CD, Venkatakrishnan K, Leonard EJ, Shustov AR

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37, 613-623 dx.doi.org/10.1200/JCO.18.00899

Descriptive epidemiology, genetics and cancer prevention , Haematology

Solans M, Fàbrega A, Morea D, Auñon-Sanz C, Granada I, Roncero JM, Blanco A, Kelleher N, Buch J, Saez M, Marcos-Gragera R

Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain

CANCER EPIDEMIOLOGY, 2019, 58, 8-11 dx.doi.org/10.1016/j.canep.2018.11.001

Directori

Publicacions

Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.

Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma.

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.

Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

Follicular dendritic cell tumor in the context of a Castleman disease in a patient with Diffuse Large B Cell Lymphoma: Diagnosis and follow-up with 18 F-FDG PET/CT.

Utility of the 18 F-FDG PET/CT in the diagnosis of the neurolymphomatosis: A case report.

Population-based survival of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain

Utility of the 18F-FDG PET/CT in the diagnosis of the neurolymphomatosis: a case report

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain

Formulari de contacte

About IDIBGI!